Rosuvastatin Clinical Trials Rosuvastatin RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg
Conditions:   Coronary Artery Disease;   Dyslipidemias Intervention:   Drug: a high dose of statin/ezetimib Sponsors:   Yonsei University;   dotter Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2023 Category: Research Source Type: clinical trials

A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants
Condition:   Healthy Interventions:   Drug: Rosuvastatin;   Drug: Selpercatinib Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg
Conditions:   Coronary Artery Disease;   Dyslipidemias Intervention:   Drug: a high dose of statin/ezetimib Sponsors:   Yonsei University;   dotter Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants
Condition:   Healthy Interventions:   Drug: Rosuvastatin;   Drug: Selpercatinib Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg
Conditions:   Coronary Artery Disease;   Dyslipidemias Intervention:   Drug: a high dose of statin/ezetimib Sponsors:   Yonsei University;   dotter Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants
Condition:   Healthy Interventions:   Drug: Rosuvastatin;   Drug: Selpercatinib Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg
Conditions:   Coronary Artery Disease;   Dyslipidemias Intervention:   Drug: a high dose of statin/ezetimib Sponsors:   Yonsei University;   dotter Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants
Condition:   Healthy Interventions:   Drug: Rosuvastatin;   Drug: Selpercatinib Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg
Conditions:   Coronary Artery Disease;   Dyslipidemias Intervention:   Drug: a high dose of statin/ezetimib Sponsors:   Yonsei University;   dotter Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants
Condition:   Healthy Interventions:   Drug: Rosuvastatin;   Drug: Selpercatinib Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials